Background The diagnostic challenges associated with the COVID‐19 pandemic resulted in
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …

SARS-CoV-2 is a newly identified member of the coronavirus family that has caused the
Coronavirus disease 2019 (COVID-19) pandemic. This rapidly evolving and unrelenting …

Abstract Objective Most SARS‐CoV‐2‐infected individuals never require hospitalization.
However, some develop prolonged symptoms. We sought to characterize the spectrum of …

Abstract Background An Israeli national taskforce performed a multi-center clinical and
analytical validation of seven serology assays to determine their utility and limitations for …

Objective We characterized the evolution of neurologic symptoms and self‐perceived
recovery of non‐hospitalized COVID‐19 “long haulers” 6–9 months after their initial Neuro …

An update is available for this article. Background: The clinical significance of the antibody
response after SARS-CoV-2 infection remains unclear. Purpose: To synthesize evidence on …

Objectives The coronavirus disease 2019 (COVID-19), caused by the novel betacoronavirus
severe acute respiratory syndrome 2 (SARS-CoV-2), was declared a pandemic in March …

Abstract Objectives Coronavirus disease-19 (COVID-19) pandemic became the greatest
public health challenge globally. Study of dynamicity and durability of naturally developed …

Background Understanding the long-term kinetic characteristics of SARS-CoV-2 antibodies
and the impact of inactivated vaccines on SARS-CoV-2 antibodies in convalescent patients …

Current SARS-CoV-2 serological assays generate discrepant results, and the longitudinal
characteristics of antibodies targeting various antigens after asymptomatic to mild COVID-19 …